SCHEMBL5067376

SCHEMBL5067376

CCCCC(=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1367098 0.92 FAAH (0.73)
SCHEMBL6899719 0.90 FAAH (0.77)
SCHEMBL28767487 0.90 FAAH (0.77)
SCHEMBL29287856 0.90 FAAH (0.77)
SCHEMBL3950801 0.90 FAAH (0.77)
SCHEMBL5126810 0.90 FAAH (0.77)
SCHEMBL8458168 0.90 FAAH (0.77)
SCHEMBL6344027 0.90 FAAH (0.77)
SCHEMBL609881 0.90 FAAH (0.77)
SCHEMBL5083248 0.90 FAAH (0.77)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0322184-B1 N-(2-ALKYL-3-MERCAPTO-1,5-DI-OXOALKYL)GLYCINAMIDE DERIVATIVES AND THEIR USE AS COLLAGENASE INHIBITORS BEECHAM GROUP PLC (GB) 1992-12-02 EP claimed
WO-2024102633-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES MERCK SHARP & DOHME LLC (US) 2024-05-16 WO disclosed
US-20200248041-A1 ACTIVATOR FOR ACCELERATED ADHESION DEVELOPMENT SIKA TECHNOLOGY AG (CH) 2020-08-06 US disclosed
EP-3688052-A1 ACTIVATOR FOR ACCELERATED ADHESION DEVELOPMENT Sika Technology AG (CH) 2020-08-05 EP disclosed
US-10428108-B2 Difluoroketamide derivatives HOFFMANN-LA ROCHE INC. (US) 2019-10-01 US disclosed
CN-107814938-A The preparation method of fluorine silicon nonionic surfactant 九江学院 2018-03-20 CN disclosed
US-20180057526-A1 NEW DIFLUOROKETAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-03-01 US disclosed
CN-104817472-A Novel gossypol derivatives, and preparation method and antineoplastic application thereof UNIV WUHAN 2015-08-05 CN disclosed
CN-103917578-A Bulk hydrophilic funtionalization of polyamide 46 ENCUBATOR AB 2014-07-09 CN disclosed
CN-102414241-A Microencapsulated composition containing imidazole compound, curable composition using same, and masterbatch-type curing agent ASAHI KASEI E MATERIALS CORP 2012-04-11 CN disclosed
US-7884199-B2 computer aided drug design; pharmacogenetics around telaprevir resistance; hepatitis C virus (HCV) VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-08 US disclosed
US-20090191555-A1 HCV NS3-NS4 Protease Resistance Mutants VERTEX PHARMACEUTICALS (US) 2009-07-30 US disclosed
US-20080261286-A1 Methods for producing optically active alpha-hydroxy amides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2008-10-23 US disclosed
US-20050202545-A1 Methods for producing optically active alpha-hydroxy amides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-15 US disclosed
CN-1180478-A Butachlor-oxidiazon emulsifiable concentrate and preparation technique NANTONG CITY PLANT PROTECTION (CN) 1998-05-06 CN disclosed
EP-0440506-B1 Derivatized ethylene alpha-olefin polymer useful as multifunctional viscosity index improver EXXON CHEMICAL PATENTS INC (US) 1995-05-10 EP disclosed
EP-0440506-A2 Derivatized ethylene alpha-olefin polymer useful as multifunctional viscosity index improver EXXON CHEMICAL PATENTS INC. (US) 1991-08-07 EP disclosed